Villanova Investment Management Co LLC Purchases 11,305 Shares of Ingevity Co. (NYSE:NGVT)

Villanova Investment Management Co LLC increased its position in Ingevity Co. (NYSE:NGVT - Free Report) by 30.4% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 48,459 shares of the company's stock after acquiring an additional 11,305 shares during the quarter. Ingevity comprises about 2.0% of Villanova Investment Management Co LLC's investment portfolio, making the stock its 20th biggest position. Villanova Investment Management Co LLC owned about 0.13% of Ingevity worth $1,890,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. First Horizon Advisors Inc. boosted its position in shares of Ingevity by 809.2% in the second quarter. First Horizon Advisors Inc. now owns 591 shares of the company's stock valued at $26,000 after acquiring an additional 526 shares during the period. Blue Trust Inc. raised its stake in Ingevity by 101.8% during the 2nd quarter. Blue Trust Inc. now owns 896 shares of the company's stock valued at $43,000 after purchasing an additional 452 shares during the last quarter. Headlands Technologies LLC bought a new stake in Ingevity in the 2nd quarter valued at $46,000. KBC Group NV grew its position in Ingevity by 50.8% in the 3rd quarter. KBC Group NV now owns 1,574 shares of the company's stock worth $61,000 after purchasing an additional 530 shares during the last quarter. Finally, nVerses Capital LLC bought a new position in shares of Ingevity during the 3rd quarter worth about $113,000. Institutional investors and hedge funds own 91.59% of the company's stock.

Analysts Set New Price Targets

Separately, BMO Capital Markets increased their target price on shares of Ingevity from $40.00 to $47.00 and gave the company a "market perform" rating in a research note on Thursday, October 31st. Three equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average price target of $52.17.

Ingevity Stock Up 2.4 %

Shares of Ingevity stock traded up $1.09 during trading on Friday, hitting $47.11. 237,525 shares of the company's stock traded hands, compared to its average volume of 238,382. The firm's fifty day moving average price is $41.24 and its 200 day moving average price is $41.67. Ingevity Co. has a twelve month low of $30.90 and a twelve month high of $56.29. The company has a debt-to-equity ratio of 6.52, a current ratio of 1.76 and a quick ratio of 1.04.

Ingevity (NYSE:NGVT - Get Free Report) last released its quarterly earnings data on Tuesday, October 29th. The company reported $1.10 earnings per share for the quarter, beating analysts' consensus estimates of $0.60 by $0.50. Ingevity had a positive return on equity of 24.46% and a negative net margin of 38.11%. The company had revenue of $376.90 million for the quarter, compared to the consensus estimate of $376.95 million. During the same period in the previous year, the business earned $1.21 earnings per share. The company's quarterly revenue was down 15.5% on a year-over-year basis. As a group, equities analysts anticipate that Ingevity Co. will post 2.55 EPS for the current fiscal year.

Ingevity Company Profile

Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies.